PLAGENTRA SOOTHING REVOLUTION BB

Manufacturer
C.A Pharm Co., Ltd.
Effective date
2014-12-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:41:01

Label at a glance#

ProductPLAGENTRA SOOTHING REVOLUTION BB
Active ingredientTitanium Dioxide, OCTINOXATE, Zinc Oxide
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Titanium Dioxide 9.24%, Ethylhexyl Methoxycinnamate 7.5%, Zinc Oxide 1.17%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients:
Water, Cyclopentasiloxane, Butylene Glycol, Ethylhexyl Triazone, Di-C12-13 Alkyl Tartrate, Cetyl Ethylhexanoate, Dicaprylyl Carbonate, Cetyl PEG/PPG-10/1 Dimethicone, Glycerin, PEG-10 Dimethicone, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, 1,2-Hexanediol, Polyglyceryl-4 Isostearate, Hydrated Silica, Sodium Chloride, Magnesium Sulfate, CI 77492, Quaternium-18 Bentonite, Copernicia Cerifera (Carnauba) Wax, Ozokerite, Hydrogen Dimethicone, Aloe Arborescens Leaf Extract, Bisabolol, Beeswax, Aluminum Hydroxide, Dimethicone Crosspolymer, CI 77491, Polyglutamic Acid, Triethoxycaprylylsilane, CI 77499, Caprylic/Capric Triglyceride, Tocopheryl Acetate, Chamomilla Recutita (Matricaria) Flower/Leaf Extract, Eugenia Caryophyllus (Clove) Flower Extract, Citrus Paradisi (Grapefruit) Fruit Extract, Eucalyptus Globulus Leaf Extract, Citrus Junos Fruit Extract, Sophora Angustifolia Root Extract, Centella Asiatica Extract, Scutellaria Baicalensis Root Extract, Polygonum Cuspidatum Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Anthemis Nobilis Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Polysorbate 80, Allantoin, Dipotassium Glycyrrhizate, Alcohol, Adenosine, Lecithin, Ubiquinone

PURPOSE

OTC - PURPOSE SECTION

Purpose: UVA/UVB Protection

WARNINGS

WARNINGS SECTION

Warnings:
1. Stop using the product and go to a doctor immediately if one of the following symptoms occurs. If immediate care is not sought, the symptoms may worsen :
1) Itching, redness, swelling, rash, etc. 2) If one of the symptoms above occurs due to direct sunlight.
2. Do not apply the product to wounds or skin with dermatitis such as eczema.
3. Storage and Handling, 1) Keep the lid closed after use. 2) Keep the product out of children's reach. 3) Keep away from direct sunlight, do not store at high or low temperature.
4. It contains AHA. If it is your first time to use this product, take a small amount and gently apply to the skin to check if it cause andy trouble to your skin.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of babies and children.

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indication and usage:
1) Tighten the lid after using it.
2) Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.
3) Using your fingertips, dab it onto any target areas, particularly underneath the eyes. Then slowly begin blending in a circular motion.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage and administration:
Get an appropriate amount of BB cream apply them onto your face and use gentle patting motions to spread and blend it into your skin.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ZINC CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130889416000008GTIN-13: 0889416000008
EAN-13: 0889416000008
GTIN-12: 889416000008
UPC-A: 889416000008
GTIN storage (14 digits): 00889416000008
plagentra soothing revolution bb carton.jpg
QR code linkQR Codewww.capharm.co.kr/plagentra soothing revolution bb carton.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68988-110-012020-01-31C16284748780-19d75b9d0-0e7d-f424-e053-dadaa90a57cef1d8a3de-a9cf-4d26-896e-8dff72d0eec1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68988-110-01PLAGENTRA SOOTHING REVOLUTION BB30 g in 1 CARTONCREAM302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68988-110PLAGENTRA SOOTHING REVOLUTION BB (TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE) CREAM [C.A PHARM CO., LTD.]2Legacy NDC, 1 package rows20141205_f1d8a3de-a9cf-4d26-896e-8dff72d0eec1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD512
Titanium DioxideACTIVE INGREDIENT15FIX9V2JP2
Zinc OxideACTIVE INGREDIENTSOI2LOH54Z2
OCTINOXATEACTIVE MOIETY4Y5P7MUD512
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP2
ZINC CATIONACTIVE MOIETY13S1S8SF372
Butylene GlycolINACTIVE INGREDIENT3XUS85K0RA2
WaterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68988-11068988-110-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1c5a2989-d244-4468-b01b-3ac337d33ee0f1d8a3de-a9cf-4d26-896e-8dff72d0eec12014-12-05WarningsExact identifier
spl id: 1c5a2989-d244-4468-b01b-3ac337d33ee0
spl set id: f1d8a3de-a9cf-4d26-896e-8dff72d0eec1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.